These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

363 related items for PubMed ID: 24001613

  • 1. Nir1 promotes invasion of breast cancer cells by binding to chemokine (C-C motif) ligand 18 through the PI3K/Akt/GSK3β/Snail signalling pathway.
    Zhang B, Yin C, Li H, Shi L, Liu N, Sun Y, Lu S, Liu Y, Sun L, Li X, Chen W, Qi Y.
    Eur J Cancer; 2013 Dec; 49(18):3900-13. PubMed ID: 24001613
    [Abstract] [Full Text] [Related]

  • 2. CCL18 promotes the invasion and metastasis of breast cancer through Annexin A2.
    Zhao C, Zheng S, Yan Z, Deng Z, Wang R, Zhang B.
    Oncol Rep; 2020 Feb; 43(2):571-580. PubMed ID: 31894281
    [Abstract] [Full Text] [Related]

  • 3. CCL18-NIR1 promotes oral cancer cell growth and metastasis by activating the JAK2/STAT3 signaling pathway.
    Jiang X, Huang Z, Sun X, Zheng X, Liu J, Shen J, Jia B, Luo H, Mai Z, Chen G, Zhao J.
    BMC Cancer; 2020 Jul 08; 20(1):632. PubMed ID: 32641093
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Leptin promotes epithelial-mesenchymal transition of breast cancer via the upregulation of pyruvate kinase M2.
    Wei L, Li K, Pang X, Guo B, Su M, Huang Y, Wang N, Ji F, Zhong C, Yang J, Zhang Z, Jiang Y, Liu Y, Chen T.
    J Exp Clin Cancer Res; 2016 Oct 21; 35(1):166. PubMed ID: 27769315
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. BMP2 accelerates the motility and invasiveness of gastric cancer cells via activation of the phosphatidylinositol 3-kinase (PI3K)/Akt pathway.
    Kang MH, Kim JS, Seo JE, Oh SC, Yoo YA.
    Exp Cell Res; 2010 Jan 01; 316(1):24-37. PubMed ID: 19835871
    [Abstract] [Full Text] [Related]

  • 10. TNF-α induces epithelial-mesenchymal transition of renal cell carcinoma cells via a GSK3β-dependent mechanism.
    Ho MY, Tang SJ, Chuang MJ, Cha TL, Li JY, Sun GH, Sun KH.
    Mol Cancer Res; 2012 Aug 01; 10(8):1109-19. PubMed ID: 22707636
    [Abstract] [Full Text] [Related]

  • 11. Effect of LY294002 on adriamycin-induced epithelial-mesenchymal transition in human breast carcinoma cells.
    Qian YJ, Cheng XM, Wang B, Xu L, Wu CJ, Zhao ML, Qi XH, Guo J.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2012 Aug 01; 34(4):319-23. PubMed ID: 22954111
    [Abstract] [Full Text] [Related]

  • 12. Thioredoxin 1 mediates TGF-β-induced epithelial-mesenchymal transition in salivary adenoid cystic carcinoma.
    Jiang Y, Feng X, Zheng L, Li SL, Ge XY, Zhang JG.
    Oncotarget; 2015 Sep 22; 6(28):25506-19. PubMed ID: 26325518
    [Abstract] [Full Text] [Related]

  • 13. RAGE-binding S100A8/A9 promotes the migration and invasion of human breast cancer cells through actin polymerization and epithelial-mesenchymal transition.
    Yin C, Li H, Zhang B, Liu Y, Lu G, Lu S, Sun L, Qi Y, Li X, Chen W.
    Breast Cancer Res Treat; 2013 Nov 22; 142(2):297-309. PubMed ID: 24177755
    [Abstract] [Full Text] [Related]

  • 14. Discovery of CCL18 antagonist blocking breast cancer metastasis.
    Liu Y, Zheng H, Li Q, Li S, Lai H, Song E, Li D, Chen J.
    Clin Exp Metastasis; 2019 Jun 22; 36(3):243-255. PubMed ID: 31062206
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. IL-7 splicing variant IL-7δ5 induces EMT and metastasis of human breast cancer cell lines MCF-7 and BT-20 through activation of PI3K/Akt pathway.
    Yang J, Zeng Z, Peng Y, Chen J, Pan L, Pan D.
    Histochem Cell Biol; 2014 Oct 22; 142(4):401-10. PubMed ID: 24770666
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. CCL18 from tumor-associated macrophages promotes angiogenesis in breast cancer.
    Lin L, Chen YS, Yao YD, Chen JQ, Chen JN, Huang SY, Zeng YJ, Yao HR, Zeng SH, Fu YS, Song EW.
    Oncotarget; 2015 Oct 27; 6(33):34758-73. PubMed ID: 26416449
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Livin promotes progression of breast cancer through induction of epithelial-mesenchymal transition and activation of AKT signaling.
    Li F, Yin X, Luo X, Li HY, Su X, Wang XY, Chen L, Zheng K, Ren GS.
    Cell Signal; 2013 Jun 27; 25(6):1413-22. PubMed ID: 23524337
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.